GS
| |
GILEAD SCIENCES, INC.13F | |
| GILEAD SCIENCES, INC. | |
| Last update 2025-05-13 | 14 Stocks (1 new) |
| Value $1.18 Bil | Turnover 1 % |
GILEAD SCIENCES, INC. Top Holdings of 2025-03-31
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ACLX | Arcellx Inc | 6,720,803 | 440,884.7 | 0% | 37.320 | 0% | 12.200 | +24.98% | -12.65% | 3,691.6 | Biotechnology | |
GLPG | Galapagos NV | 16,707,477 | 419,394.3 | 0% | 35.500 | 0% | 25.350 | +20.79% | +3.31% | 1,872.2 | Biotechnology | |
RCUS | Arcus Biosciences Inc | 31,424,760 | 246,684.4 | +4.54% | 20.880 | +0.91% | 29.680 | +19.96% | -43.28% | 894.2 | Biotechnology | |
ASMB | Assembly Biosciences Inc | 2,209,471 | 21,122.5 | 0% | 1.790 | 0% | 28.920 | +126.03% | +18.31% | 142.6 | Biotechnology | |
MRUS | Merus NV | 452,527 | 19,046.9 | 0% | 1.610 | 0% | 0.650 | +53.31% | +27.21% | 3,983.8 | Biotechnology | |
KYTX | Kyverna Therapeutics Inc | 4,126,119 | 7,963.4 | 0% | 0.670 | 0% | 9.550 | +36.36% | -31.82% | 110.2 | Biotechnology | |
TNGX | Tango Therapeutics Inc | 4,854,443 | 6,650.6 | 0% | 0.560 | 0% | 4.490 | +361.16% | +80.58% | 604.8 | Biotechnology | |
XLO | Xilio Therapeutics Inc | 9,105,451 | 6,596.0 | 0% | 0.560 | 0% | 17.580 | +9.53% | -25.95% | 36.6 | Biotechnology | |
KLRS | Kalaris Therapeutics Inc | 723,273 | 5,807.9 | New Holding | 0.490 | +0.49% | 3.870 | -63.08% | 0% | 48.8 | Biotechnology | |
HOOK | HOOKIPA Pharma Inc | 1,875,945 | 2,026.0 | 0% | 0.170 | 0% | 15.400 | +52.93% | -42.79% | 14.0 | Biotechnology |
GILEAD SCIENCES, INC.'s Historical Top Holdings Breakdowns
GILEAD SCIENCES, INC.'s Top Stock Picks
View Full List
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
RCUS | Arcus Biosciences Inc | 2025-03-31 | Add Add | +0.91% | 7.85 ($11.59) 15.24 | $8.45 | -27.14% | Add 4.54% | 31,424,760 | 1,363,636 | |
KLRS | Kalaris Therapeutics Inc | 2025-03-31 | New Buy New Buy | +0.49% | 8.03 ($9.78) 11.47 | $2.61 | -73.31% | New holding | 723,273 | 723,273 | |
ALVR | AlloVir Inc | 2025-03-31 | Sold Out Sold Out | -0.45% | 8.77 ($9.79) 10.96 | $9.81 | 0.20% | Sold Out | 0 | -723,274 | |
IKNA | Ikena Oncology Inc | 2025-03-31 | Reduce Reduce | -0.09% | 1.28 ($1.44) 1.69 | $1.35 | -6.25% | Reduce -42.28% | 1,159,145 | -849,193 | |
AGEN | Agenus Inc | 2025-03-31 | Sold Out Sold Out | -0.04% | 1.51 ($2.88) 3.9 | $5.20 | 80.56% | Sold Out | 0 | -231,663 | |
BRNS | Barinthus Biotherapeutics PLC | 2025-03-31 | Reduce Reduce | -0.02% | 0.93 ($1.03) 1.24 | $0.95 | -7.41% | Reduce -40.38% | 369,855 | -250,496 | |
KRON | Kronos Bio Inc | 2025-03-31 | Sold Out Sold Out | -0.01% | 0.83 ($0.96) 1.07 | $0.88 | -8.33% | Sold Out | 0 | -188,567 |
GILEAD SCIENCES, INC. Total Holding History ($B)
GILEAD SCIENCES, INC.'s Asset Allocation
GILEAD SCIENCES, INC. Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
GILEAD SCIENCES, INC.'s Hypothetical Growth since 2025-03-31
GILEAD SCIENCES, INC.'s Yearly Returns
| Year | Portfolio % | % | Excess Gain % |
|---|
GILEAD SCIENCES, INC.'s Holdings Heat Map
Size field:
GILEAD SCIENCES, INC.'s Holdings Bubble Chart
GILEAD SCIENCES, INC. News
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers